With the dapivirine vaginal ring and injectable cabotegravir poised to join oral pre-exposure prophylaxis (PrEP) as safe, effective HIV prevention products, people seeking an HIV prevention method that works for them will soon have real choices.
Continue ReadingCategory: Research
NOVEL HIV PREVENTION PRODUCTS: EXPANDING THE EVIDENCE FOR INTRODUCTION
When countries introduce novel HIV prevention products, such as the PrEP ring and injectable CAB PrEP, how will women decide which product to use, and what will influence those decisions?
Continue Reading“THESE NEW PRODUCTS GIVE ME POWER AND CONTROL OVER MY LIFE AND HEALTH”: CELEBRATING CHOICE ON INTERNATIONAL WOMEN’S DAY
Today, we observe International Women’s Day, a day to celebrate the many achievements of women around the globe.
Continue ReadingWHAT’S NEXT FOR CAB PrEP?
In this webinar, we explore ongoing and completed research on CAB PrEP, learn about the recently released FDA guidance, and hear from a panel of implementers and policymakers on what is needed to advance introduction of this new HIV prevention product.
Continue Reading